HYRIMOZ 20 mg/.2mL
adalimumab-adaz · INJECTION, SOLUTION · Sandoz Inc
No Recall History
Plain English
HYRIMOZ is a injection, solution containing adalimumab-adaz at 20 mg/.2mL, taken subcutaneous. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- HYRIMOZ
- Generic Name
- adalimumab-adaz
- NDC Code (Product)
61314-476- Manufacturer
- Sandoz Inc
- Strength
- 20 mg/.2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761071
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 07/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is HYRIMOZ used for?
HYRIMOZ contains adalimumab-adaz. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is HYRIMOZ a controlled substance?
HYRIMOZ is not classified as a controlled substance by the DEA.
What is the generic name for HYRIMOZ?
The generic name for HYRIMOZ is adalimumab-adaz. There are 2 other brand versions of adalimumab-adaz.
What is the NDC code for HYRIMOZ 20 mg/.2mL?
The NDC (National Drug Code) for HYRIMOZ 20 mg/.2mL is 61314-476, listed by Sandoz Inc.